Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-06-13

FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Potassium Chloride from Baxter Healthcare Corporation, indicating a labeling update for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium chloride (Potassium chloride)

Snippet

SUPPL AP for POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)